Inventor · disambiguated record
Kenneth Dobie
Also filed as: DOBIE KENNETH · DOBIE KENNETH W
76 granted patents·251 pending applications·1,752 citations·filing 2001–2021
99Inventor score
Files withISIS PHARMACEUTICALS INC226DOBIE KENNETH W13BHANOT SANJAY11BENNETT C F10IONIS PHARMACEUTICALS INC9
Top patents by PatentIndex Score
327 records- 0199US7468431B2Modulation of eIF4E-BP2 expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Dec 23, 2008·117 cites·30 claims
- 0299US7217572B2Modulation of HIF1α and HIF2α expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted May 15, 2007·139 cites·18 claims
- 0398US7732590B2Modulation of diacylglycerol acyltransferase 2 expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Jun 8, 2010·132 cites·31 claims
- 0498US7598227B2Modulation of apolipoprotein C-III expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Oct 6, 2009·292 cites·28 claims
- 0598US7144999B2Modulation of hypoxia-inducible factor 1 alpha expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Dec 5, 2006·115 cites·24 claims
- 0697US8258109B2Compositions and methods for modulation of LMNA expressionBENNETT C FRANK·Filed 2006·Granted Sep 4, 2012·44 cites·17 claims
- 0797US7902163B2Antisense modulation of superoxide dismutase 1, soluble expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Mar 8, 2011·34 cites·17 claims
- 0897US7750141B2Modulation of apolipoprotein c-III expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 6, 2010·64 cites·18 claims
- 0997US7399853B2Modulation of glucagon receptor expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 15, 2008·105 cites·26 claims
- 1097US7199107B2Antisense modulation of kinesin-like 1 expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 3, 2007·128 cites·45 claims
- 1197US7033830B2Antisense modulation of MyD88 expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 25, 2006·94 cites·13 claims
- 1296US7229976B2Modulation of forkhead box O1A expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Jun 12, 2007·114 cites·35 claims
- 1396US6617162B2Antisense modulation of estrogen receptor alpha expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Sep 9, 2003·57 cites·13 claims
- 1494US7132530B2Antisense modulation of superoxide dismutase 1, soluble expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Nov 7, 2006·38 cites·22 claims
- 1593US8258289B2Modulation of diacylglycerol acyltransferase 2 expressionBHANOT SANJAY·Filed 2010·Granted Sep 4, 2012·20 cites·24 claims
- 1692US8993529B2Antisense modulation of superoxide dismutase 1, soluble expressionBENNETT C FRANK·Filed 2011·Granted Mar 31, 2015·12 cites·15 claims
- 1792US8530439B2Modulation of apolipoprotein C-III expressionCROOKE ROSANNE M·Filed 2010·Granted Sep 10, 2013·13 cites·48 claims
- 1892US6716627B2Antisense modulation of mucin 1, transmembrane expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Apr 6, 2004·27 cites·13 claims
- 1990US8791088B2Compositions and methods for modulation of LMNA expressionBENNETT C FRANK·Filed 2012·Granted Jul 29, 2014·6 cites·18 claims
- 2090US7507808B2Modulation of endothelial lipase expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Mar 24, 2009·17 cites·21 claims
- 2190US7425544B2Modulation of eIF4E expressionLILLY CO ELI·Filed 2004·Granted Sep 16, 2008·26 cites·16 claims
- 2289US8669102B2Modulation of prion expressionBENNETT C FRANK·Filed 2009·Granted Mar 11, 2014·5 cites·30 claims
- 2388US9476051B2Antisense modulation of superoxide dismutase 1, soluble expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Oct 25, 2016·5 cites·20 claims
- 2487US8921331B2Methods for slowing familial ALS disease progressionBENNETT C FRANK·Filed 2012·Granted Dec 30, 2014·7 cites·20 claims
- 2587US7960358B2Antisense modulation of stearoyl-CoA desaturase expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Jun 14, 2011·3 cites·17 claims
- 2686US9624496B2Modulation of apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·3 cites·22 claims
- 2785US7718628B2Antisense modulation of kinesin-like 1 expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted May 18, 2010·4 cites·19 claims
- 2885US6852536B2Antisense modulation of CD36L 1 expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Feb 8, 2005·15 cites·10 claims
- 2985US6743909B2Antisense modulation of PTPN12 expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Jun 1, 2004·9 cites·12 claims
- 3084US8017760B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·4 cites·13 claims
- 3184US7759479B1Compositions and their uses directed to Gemin GenesISIS PHARMACEUTICALS INC·Filed 2005·Granted Jul 20, 2010·5 cites·21 claims
- 3284US7601700B2Modulation of eIF4E expressionLILLY CO ELI·Filed 2008·Granted Oct 13, 2009·4 cites·16 claims
- 3383US7585968B2Compositions and their uses directed to thymus and activation-regulated chemokine (TARC)ISIS PHARMACEUTICALS INC·Filed 2006·Granted Sep 8, 2009·4 cites·30 claims
- 3483US6828151B2Antisense modulation of hematopoietic cell protein tyrosine kinase expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Dec 7, 2004·10 cites·13 claims
- 3582US9157082B2Modulation of apolipoprotein CIII (ApoCIII) expressionMULLICK ADAM·Filed 2012·Granted Oct 13, 2015·7 cites·45 claims
- 3682US9139831B2Modulation of angiopoietin-like 3 expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·3 cites·29 claims
- 3782US7807649B2Modulation of forkhead box O1A expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Oct 5, 2010·4 cites·33 claims
- 3881US9856473B2Compositions and methods for modulation of LMNA expressionIONIS PHARMACEUTICLS INC·Filed 2014·Granted Jan 2, 2018·3 cites·14 claims
- 3981US8865884B2Antisense modulation of kinesin-like 1 expressionISIS PHARMACEUTICALS INC·Filed 2013·Granted Oct 21, 2014·1 cites·17 claims
- 4081US8623836B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionTACHAS GEORGE·Filed 2010·Granted Jan 7, 2014·5 cites·25 claims
- 4181US8470795B2Antisense modulation of kinesin-like 1 expressionDOBIE KENNETH W·Filed 2010·Granted Jun 25, 2013·2 cites·54 claims
- 4281US7897583B2Compositions and their uses directed to PTPRUISIS PHARMACEUTICALS INC·Filed 2006·Granted Mar 1, 2011·4 cites·36 claims
- 4381US7618947B2Modulation of HIF-1 beta expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Nov 17, 2009·4 cites·32 claims
- 4481US7163927B2Antisense modulation of kinesin-like 1 expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Jan 16, 2007·11 cites·19 claims
- 4580US8410074B2Modulation of eIF4E expressionDOBIE KENNETH W·Filed 2012·Granted Apr 2, 2013·3 cites·14 claims
- 4679US8227593B2Modulation of forkhead box O1A expressionDOBIE KENNETH W·Filed 2010·Granted Jul 24, 2012·3 cites·19 claims
- 4778US11225664B2Modulation of angiopoietin-like 3 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Jan 18, 2022·0 cites·17 claims
- 4878US8642753B2Modulation of glucagon receptor expressionFREIER SUSAN M·Filed 2012·Granted Feb 4, 2014·2 cites·20 claims
- 4976US8299039B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionTACHAS GEORGE·Filed 2004·Granted Oct 30, 2012·9 cites·22 claims
- 5076US7563885B1Modulation of Tudor-SN expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Jul 21, 2009·2 cites·16 claims
Showing the top 50 of 327 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →